Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria

Stopped Study was terminated early by sponsor due to the challenges and risks introduced by Coronavirus disease 2019 (COVID-19) pandemic.

Conditions

• Pseudomonas Aeruginosa Respiratory Tract Infection/Colonization
• Cystic Fibrosis

Interventions

• DRUG: AZLI
• DRUG: Placebo

Sponsor

Gilead Sciences